Gong et al., using multiple human PC cells, found that the combination treatment with nexrutine and gemcitabine resulted in significant alterations of proteins in the STAT3/NF-κB signaling axis, and growth inhibition in a synergistic manner [66]. The gene discussed is NFKB1; the disease is pachyonychia congenita.